GrippeCanadaV3, Main, Exploration, bibRecord, 000908

Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.

Identifieur interne : 000908 ( Main/Exploration ); précédent : 000907; suivant : 000909

Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.

Auteurs : Joanne M. Langley ; Marie E. Faughnan

Source :

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [ 0820-3946 ] ; 2004.

RBID : pubmed:15534308

Descripteurs français

KwdFr :
- Acides sialiques (usage thérapeutique), Acétamides (effets indésirables), Acétamides (usage thérapeutique), Adulte d'âge moyen, Canada, Facteurs de risque, Grippe humaine (), Guanidines, Humains, Médecine préventive (normes), Nourrisson, Oséltamivir, Politique de santé, Pyrannes, Santé publique, Sialidase (antagonistes et inhibiteurs), Sujet âgé, Vaccins antigrippaux (effets indésirables), Zanamivir.
MESH :
- antagonistes et inhibiteurs : Sialidase.
- effets indésirables : Acétamides, Vaccins antigrippaux.
- normes : Médecine préventive.
- usage thérapeutique : Acides sialiques, Acétamides.
- Adulte d'âge moyen, Canada, Facteurs de risque, Grippe humaine, Guanidines, Humains, Nourrisson, Oséltamivir, Politique de santé, Pyrannes, Santé publique, Sujet âgé, Zanamivir.
Wicri :
- geographic : Canada.

English descriptors

KwdEn :
- Acetamides (adverse effects), Acetamides (therapeutic use), Aged, Canada, Guanidines, Health Policy, Humans, Infant, Influenza Vaccines (adverse effects), Influenza, Human (prevention & control), Middle Aged, Neuraminidase (antagonists & inhibitors), Oseltamivir, Preventive Medicine (standards), Public Health, Pyrans, Risk Factors, Sialic Acids (therapeutic use), Zanamivir.
MESH :
- chemical , adverse effects : Acetamides, Influenza Vaccines.
- chemical , antagonists & inhibitors : Neuraminidase.
- chemical , therapeutic use : Acetamides, Sialic Acids.
- geographic : Canada, Guanidines, Oseltamivir, Pyrans, Zanamivir.
- prevention & control : Influenza, Human.
- standards : Preventive Medicine.
- Aged, Health Policy, Humans, Infant, Middle Aged, Public Health, Risk Factors.

DOI: 10.1503/cmaj.1041375
PubMed: 15534308

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000974
to stream Main, to step Curation: 000974

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.</title>
<author><name sortKey="Langley, Joanne M" sort="Langley, Joanne M" uniqKey="Langley J" first="Joanne M" last="Langley">Joanne M. Langley</name>
<affiliation><nlm:affiliation>Canadian Task Force on Preventive Health Care, London, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Faughnan, Marie E" sort="Faughnan, Marie E" uniqKey="Faughnan M" first="Marie E" last="Faughnan">Marie E. Faughnan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15534308</idno>
<idno type="pmid">15534308</idno>
<idno type="doi">10.1503/cmaj.1041375</idno>
<idno type="wicri:Area/Main/Corpus">000974</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000974</idno>
<idno type="wicri:Area/Main/Curation">000974</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000974</idno>
<idno type="wicri:Area/Main/Exploration">000974</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.</title>
<author><name sortKey="Langley, Joanne M" sort="Langley, Joanne M" uniqKey="Langley J" first="Joanne M" last="Langley">Joanne M. Langley</name>
<affiliation><nlm:affiliation>Canadian Task Force on Preventive Health Care, London, ON.</nlm:affiliation>
<wicri:noCountry code="subField">ON</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Faughnan, Marie E" sort="Faughnan, Marie E" uniqKey="Faughnan M" first="Marie E" last="Faughnan">Marie E. Faughnan</name>
</author>
</analytic>
<series><title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title>
<idno type="ISSN">0820-3946</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acetamides (adverse effects)</term>
<term>Acetamides (therapeutic use)</term>
<term>Aged</term>
<term>Canada</term>
<term>Guanidines</term>
<term>Health Policy</term>
<term>Humans</term>
<term>Infant</term>
<term>Influenza Vaccines (adverse effects)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Middle Aged</term>
<term>Neuraminidase (antagonists & inhibitors)</term>
<term>Oseltamivir</term>
<term>Preventive Medicine (standards)</term>
<term>Public Health</term>
<term>Pyrans</term>
<term>Risk Factors</term>
<term>Sialic Acids (therapeutic use)</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Acides sialiques (usage thérapeutique)</term>
<term>Acétamides (effets indésirables)</term>
<term>Acétamides (usage thérapeutique)</term>
<term>Adulte d'âge moyen</term>
<term>Canada</term>
<term>Facteurs de risque</term>
<term>Grippe humaine ()</term>
<term>Guanidines</term>
<term>Humains</term>
<term>Médecine préventive (normes)</term>
<term>Nourrisson</term>
<term>Oséltamivir</term>
<term>Politique de santé</term>
<term>Pyrannes</term>
<term>Santé publique</term>
<term>Sialidase (antagonistes et inhibiteurs)</term>
<term>Sujet âgé</term>
<term>Vaccins antigrippaux (effets indésirables)</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Acetamides</term>
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Neuraminidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Acetamides</term>
<term>Sialic Acids</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term>
<term>Guanidines</term>
<term>Oseltamivir</term>
<term>Pyrans</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Sialidase</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Acétamides</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Médecine préventive</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Preventive Medicine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Acides sialiques</term>
<term>Acétamides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Health Policy</term>
<term>Humans</term>
<term>Infant</term>
<term>Middle Aged</term>
<term>Public Health</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Canada</term>
<term>Facteurs de risque</term>
<term>Grippe humaine</term>
<term>Guanidines</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Oséltamivir</term>
<term>Politique de santé</term>
<term>Pyrannes</term>
<term>Santé publique</term>
<term>Sujet âgé</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15534308</PMID>
<DateCompleted><Year>2004</Year>
<Month>12</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0820-3946</ISSN>
<JournalIssue CitedMedium="Print"><Volume>171</Volume>
<Issue>10</Issue>
<PubDate><Year>2004</Year>
<Month>Nov</Month>
<Day>09</Day>
</PubDate>
</JournalIssue>
<Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title>
<ISOAbbreviation>CMAJ</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.</ArticleTitle>
<Pagination><MedlinePgn>1169-70</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Langley</LastName>
<ForeName>Joanne M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>Canadian Task Force on Preventive Health Care, London, ON.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Faughnan</LastName>
<ForeName>Marie E</ForeName>
<Initials>ME</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Canadian Task Force on Preventive Health Care</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>CMAJ</MedlineTA>
<NlmUniqueID>9711805</NlmUniqueID>
<ISSNLinking>0820-3946</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000081">Acetamides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006146">Guanidines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011714">Pyrans</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012794">Sialic Acids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.2.1.18</RegistryNumber>
<NameOfSubstance UI="D009439">Neuraminidase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>L6O3XI777I</RegistryNumber>
<NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>CMAJ. 2005 Apr 26;172(9):1161-2; author reply 1162-3</RefSource>
<PMID Version="1">15851696</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000081" MajorTopicYN="N">Acetamides</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006146" MajorTopicYN="N">Guanidines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009439" MajorTopicYN="N">Neuraminidase</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011315" MajorTopicYN="N">Preventive Medicine</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011714" MajorTopicYN="N">Pyrans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012794" MajorTopicYN="N">Sialic Acids</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>11</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>12</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>11</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15534308</ArticleId>
<ArticleId IdType="pii">171/10/1169</ArticleId>
<ArticleId IdType="doi">10.1503/cmaj.1041375</ArticleId>
<ArticleId IdType="pmc">PMC524945</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>MMWR Recomm Rep. 2004 May 28;53(RR-6):1-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15163927</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):225-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10648763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1999 Jul 14;282(2):137-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10411194</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1995 Oct 5;333(14):889-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7666874</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 1991 Feb 1;133(3):296-304</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2000847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 1982 May;115(5):736-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7081204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2001 Mar 22;344(12):889-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11259722</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2000 Oct 4;284(13):1655-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11015795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Faughnan, Marie E" sort="Faughnan, Marie E" uniqKey="Faughnan M" first="Marie E" last="Faughnan">Marie E. Faughnan</name>
<name sortKey="Langley, Joanne M" sort="Langley, Joanne M" uniqKey="Langley J" first="Joanne M" last="Langley">Joanne M. Langley</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000908 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000908 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:15534308
   |texte=   Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:15534308" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020

	Corpus GrippeCanadaV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeCanadaV3

Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.

Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki